BAFNA PHARMACEUTICALS
|
The Current P/S Ratio of BAFNA PHARMACEUTICALS is 1.71.
| Share Price | ₹106.6 | Feb 25,2026 |
| Market Cap | ₹252.6 Cr | |
| Sales-TTM | ₹147.4 Cr | TTM-Standalone Results |
| Price/Sales | 1.71x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BAFNA PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹252.6 Cr] as on Feb 25,2026
(/) Sales [ ₹147.4 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.71x ]
Thus, for BAFNA PHARMACEUTICALS , the investors are currently willing to pay '1.71 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BAFNA PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of BAFNA PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of BAFNA PHARMACEUTICALS
PS Ratio Performance Analysis for BAFNA PHARMACEUTICALS
- BAFNA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.44x.
- BAFNA PHARMACEUTICALS 's operated at median p/e ratio of 1.7x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAFNA PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 4.56x.
- BAFNA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 1.19x.
How does BAFNA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BAFNA PHARMACEUTICALS | 147.4 | 1.71 | 252.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.45 | 423,195.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.47 | 169,849.0 |
| CIPLA LTD | 28,351.1 | 3.83 | 108,703.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.74 | 149,586.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.14 | 109,054.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.39 | 88,961.6 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.55 | 92,513.1 |
| LUPIN LTD | 26,150.5 | 4.01 | 104,775.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.12 | 70,509.3 |
| ABBOTT INDIA LTD | 6,824.1 | 8.22 | 56,126.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BAFNA PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.71x |
| Max industry PS | 16.47x |
| Median industry PS | 4.01x |
| Average industry PS | 6.24x |
You may also like the below Video Courses